Literature DB >> 16081479

Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl- transport of mouse aortic smooth muscle cells.

Renaud Robert1, Caroline Norez, Frédéric Becq.   

Abstract

Chloride (Cl(-)) channels expressed in vascular smooth muscle cells (VSMC) are important to control membrane potential equilibrium, intracellular pH, cell volume maintenance, contraction, relaxation and proliferation. The present study was designed to compare the expression, regulation and function of CFTR Cl(-) channels in aortic VSMC from Cftr(+/+) and Cftr(-)(/)(-) mice. Using an iodide efflux assay we demonstrated stimulation of CFTR by VIP, isoproterenol, cAMP agonists and other pharmacological activators in cultured VSMC from Cftr(+/+). On the contrary, in cultured VSMC from Cftr(-)(/)(-) mice these agonists have no effect, showing that CFTR is the dominant Cl(-) channel involved in the response to cAMP mediators. Angiotensin II and the calcium ionophore A23187 stimulated Ca(2)(+)-dependent Cl(-) channels in VSMCs from both genotypes. CFTR was activated in myocytes maintained in medium containing either high potassium or 5-hydroxytryptamine (5-HT) and was inhibited by CFTR(inh)-172, glibenclamide and diphenylamine-2,2'-dicarboxylic acid (DPC). We also examined the mechanical properties of aortas. Arteries with or without endothelium from Cftr(-/-) mice became significantly more constricted (approximately 2-fold) than that of Cftr(+/+) mice in response to vasoactive agents. Moreover, in precontracted arteries of Cftr(+/+) mice, VIP and CFTR activators induced vasorelaxation that was altered in Cftr(-/-) mice. Our findings suggest a novel mechanism for regulation of the vascular tone by cAMP-dependent CFTR chloride channels in VSMC. To our knowledge this study is the first to report the phenotypic consequences of the loss of a Cl(-) channel on vascular reactivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081479      PMCID: PMC1474747          DOI: 10.1113/jphysiol.2005.085019

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  46 in total

1.  Expression of CLCN voltage-gated chloride channel genes in human blood vessels.

Authors:  F S Lamb; G H Clayton; B X Liu; R L Smith; T J Barna; B C Schutte
Journal:  J Mol Cell Cardiol       Date:  1999-03       Impact factor: 5.000

Review 2.  The paradox of smooth muscle physiology.

Authors:  D A Woodrum; C M Brophy
Journal:  Mol Cell Endocrinol       Date:  2001-05-25       Impact factor: 4.102

3.  Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension.

Authors:  D Debray; P Lykavieris; F Gauthier; B Dousset; A Sardet; A Munck; H Laselve; O Bernard
Journal:  J Hepatol       Date:  1999-07       Impact factor: 25.083

Review 4.  Alpha1-adrenergic hypothesis for pulmonary hypertension.

Authors:  S S Salvi
Journal:  Chest       Date:  1999-06       Impact factor: 9.410

5.  The potentiating effect of genistein on the relaxation induced by isoproterenol in rat aortic rings.

Authors:  N Satake; S Shibata
Journal:  Gen Pharmacol       Date:  1999-09

6.  Characterization of CFTR expression and chloride channel activity in human endothelia.

Authors:  A Tousson; B A Van Tine; A P Naren; G M Shaw; L M Schwiebert
Journal:  Am J Physiol       Date:  1998-12

7.  Chloride ion currents contribute functionally to norepinephrine-induced vascular contraction.

Authors:  F S Lamb; T J Barna
Journal:  Am J Physiol       Date:  1998-07

Review 8.  Structure and function of the CFTR chloride channel.

Authors:  D N Sheppard; M J Welsh
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

Review 9.  Pharmacology of CFTR chloride channel activity.

Authors:  B D Schultz; A K Singh; D C Devor; R J Bridges
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

Review 10.  Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis.

Authors:  D C Gadsby; A C Nairn
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

View more
  25 in total

1.  CFTR channels and adenosine triphosphate release: the impossible rendez-vous revisited in skeletal muscle.

Authors:  Frédéric Becq
Journal:  J Physiol       Date:  2010-12-01       Impact factor: 5.182

2.  Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(-) channel activity to maintain contraction rate.

Authors:  Zachary M Sellers; Vania De Arcangelis; Yang Xiang; Philip M Best
Journal:  J Physiol       Date:  2010-05-04       Impact factor: 5.182

3.  Cystic Fibrosis Transmembrane Conductance Regulator in Sarcoplasmic Reticulum of Airway Smooth Muscle. Implications for Airway Contractility.

Authors:  Daniel P Cook; Michael V Rector; Drake C Bouzek; Andrew S Michalski; Nicholas D Gansemer; Leah R Reznikov; Xiaopeng Li; Mallory R Stroik; Lynda S Ostedgaard; Mahmoud H Abou Alaiwa; Michael A Thompson; Y S Prakash; Ramaswamy Krishnan; David K Meyerholz; Chun Y Seow; David A Stoltz
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

Review 4.  Regulation of vascular tone and arterial blood pressure: role of chloride transport in vascular smooth muscle.

Authors:  Christian A Hübner; Björn C Schroeder; Heimo Ehmke
Journal:  Pflugers Arch       Date:  2015-01-16       Impact factor: 3.657

5.  Stimulation of murine intestinal secretion by daily genistein injections: gender-dependent differences.

Authors:  Layla Al-Nakkash; Lyn Batia; Minoti Bhakta; Amity Peterson; Nathan Hale; Ryan Skinner; Steven Sears; Jesse Jensen
Journal:  Cell Physiol Biochem       Date:  2011-08-16

6.  Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors:  Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

7.  CF airway smooth muscle transcriptome reveals a role for PYK2.

Authors:  Daniel P Cook; Ryan J Adam; Keyan Zarei; Benjamin Deonovic; Mallory R Stroik; Nicholas D Gansemer; David K Meyerholz; Kin Fai Au; David A Stoltz
Journal:  JCI Insight       Date:  2017-09-07

8.  Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.

Authors:  David K Meyerholz; David A Stoltz; Alejandro A Pezzulo; Michael J Welsh
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

9.  EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severity.

Authors:  Rebecca Darrah; Edward McKone; Clare O'Connor; Christine Rodgers; Alan Genatossio; Sharon McNamara; Ronald Gibson; J Stuart Elborn; Madeleine Ennis; Charles G Gallagher; Noor Kalsheker; Moira Aitken; Dawn Wiese; John Dunn; Paul Smith; Rhonda Pace; Douglas Londono; Katrina A B Goddard; Michael R Knowles; Mitchell L Drumm
Journal:  Physiol Genomics       Date:  2009-12-22       Impact factor: 3.107

10.  Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice.

Authors:  Maziar Divangahi; Haouaria Balghi; Gawiyou Danialou; Alain S Comtois; Alexandre Demoule; Sheila Ernest; Christina Haston; Renaud Robert; John W Hanrahan; Danuta Radzioch; Basil J Petrof
Journal:  PLoS Genet       Date:  2009-07-31       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.